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ABSTRACT: Haloalkane dehalogenase from Rhodococcus rhodochrous NCIMB 13064 (DhaA) catalyzes
the hydrolysis of carbon-halogen bonds in a wide range of haloalkanes. We examined the steady-state
and pre-steady-state kinetics of halopropane conversion by DhaA to illuminate mechanistic details of the
dehalogenation pathway. Steady-state kinetic analysis of DhaA with a range of halopropanes showed that
bromopropanes had higher kcat and lower KM values than the chlorinated analogues. The kinetic mechanism
of dehalogenation was further studied using rapid-quench-flow analysis of 1,3-dibromopropane conversion.
This provided a direct measurement of the chemical steps in the reaction mechanism, i.e., cleavage of the
carbon-halogen bond and hydrolysis of the covalent alkyl-enzyme intermediate. The results lead to a
minimal mechanism consisting of four main steps. The occurrence of a pre-steady-state burst, both for
bromide and 3-bromo-1-propanol, suggests that product release is rate-limiting under steady-state conditions.
Combining pre-steady-state burst and single-turnover experiments indicated that the rate of carbon-
bromine bond cleavage was indeed more than 100-fold higher than the steady-state kcat. Product release
occurred with a rate constant of 3.9 s-1, a value close to the experimental kcat of 2.7 s-1. Comparing the
kinetic mechanism of DhaA with that of the corresponding enzyme from Xanthobacter autotrophicus
GJ10 (DhlA) shows that the overall mechanisms are similar. However, whereas in DhlA the rate of halide
release represents the slowest step in the catalytic cycle, our results suggest that in DhaA the release of
3-bromo-1-propanol is the slowest step during 1,3-dibromopropane conversion.
Haloalkane dehalogenases comprise a group of enzymes
that hydrolyze carbon-halogen bonds in a wide range of
haloalkanes, some of which are notorious environmental
pollutants. The potential use of haloalkane dehalogenases
in bioremediation applications has stimulated intensive
investigation of these enzymes (1), and there is a growing
interest in the application of these enzymes as industrial
biocatalysts (2). Three different haloalkane dehalogenases
have been purified and characterized in detail: the enzymes
from Xanthobacter autotrophicus GJ10 (DhlA)1 (3), Sphin-
gomonas paucimobilis UT26 (LinB) (4), and Rhodococcus
rhodochrous NCIMB13064 (DhaA) (5). In addition, a
number of haloalkane dehalogenases were previously isolated
from Gram-positive haloalkane-utilizing bacterial strains
m15-3 (6), HA1 (7), GJ70 (8), and Y2 (9). However, DNA
sequencing showed that the corresponding haloalkane de-
halogenase genes of these strains were identical to the dhaA
gene of R. rhodochrous NCIMB13064 (10). The X-ray
crystal structures of the haloalkane dehalogenases DhlA (11),
LinB (12), and DhaA (13) are now available, and reveal that
the enzymes belong to the R/â-hydrolase fold superfamily
(14). Haloalkane dehalogenases have a globular structure and
are composed of two domains: a large central catalytic
domain with an R/â-hydrolase fold structure and a second
domain which lies like a cap on the main domain. The latter
domain emerges as a large R-helical excursion between
â-strands 6 and 7 of the catalytic core. The interface of the
two domains forms the hydrophobic active site. The catalytic
triad residues are a nucleophilic aspartate, a base catalyst
histidine, and an aspartate or glutamate as the third member.
These amino acids form the basis of the dehalogenation
reaction and are located in the main domain. Whereas there
is significant sequence similarity in the catalytic core, the
sequence and structure of the cap domain diverge consider-
ably between different haloalkane dehalogenases. The cap
domain was proposed to play a prominent role in determining
substrate specificity (15).
Considerable understanding of the catalytic mechanism of
haloalkane dehalogenases has emerged from studies with the
enzyme from X. autotrophicus GJ10 (DhlA) (16-20). This
enzyme contains a catalytic triad formed by Asp124, His289,
and Asp260. The overall catalytic mechanism for dehalo-
genation occurs in four kinetically distinguishable steps. After
formation of the Michaelis complex, the dehalogenation
reaction proceeds via a nucleophilic attack of Asp124 on
the halo-substituted carbon atom of the substrate, thereby
displacing the halogen ion and forming an alkyl-enzyme
intermediate. This covalent intermediate is subsequently
† This work was supported by a grant from Ciba Specialty Chemicals
Inc. (Basel, Switzerland).
* To whom correspondence should be addressed. E-mail:
D.B.Janssen@chem.rug.nl. Telephone: +31-50-3634209. Fax: +31-
50-3634165.
1 Abbreviations: DhaA, haloalkane dehalogenase from R. rhodo-
chrous; DhlA, haloalkane dehalogenase from X. autotrophicus GJ10;
LinB, haloalkane dehalogenase from S. paucimobilis UT2; SDS-
PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
8047Biochemistry 2003, 42, 8047-8053
10.1021/bi026907m CCC: $25.00 © 2003 American Chemical Society
Published on Web 06/13/2003
hydrolyzed by a water molecule activated by the dyad of
His289 and Asp260. The resulting alcohol leaves the active
site immediately, whereafter the halide ion is slowly released.
Haloalkane dehalogenase from R. rhodochrous NCI-
MB13064 (DhaA) is the first enzyme described to be
involved in the degradation of several C2-C8 n-haloalkanes
(5). The dhaA gene encodes a protein of 293 amino acids
whose sequence is 27% identical to that of DhlA. DhaA
and DhlA have conserved amino acid residues involved in
catalysis, suggesting that they have a similar reaction
mechanism, yet they are adapted to different haloalkanes
(21). Furthermore, DhaA has some structural features that
might cause details of the dehalogenation mechanism to be
different from those of DhlA. First, DhaA lacks a tryptophan
residue equivalent to Trp175 of DhlA that is involved in
substrate and halide binding. Both dehalogenases share a
similar topology of two of the three residues comprising the
catalytic triad, but the topological position of the carboxylate
functionality of the triad is different. In DhaA, it is positioned
at the end of â-strand 6, rather than after â-strand 7, as in
DhlA and most other R/â-hydrolase fold enzymes (13, 22).
DhlA and DhaA display different substrate specificities.
DhaA is most active on longer chain (C2-C8), cyclic, and
multiply halogenated alkanes. Recently, DhaA has drawn
interest because of its capacity to slowly convert the
environmentally and industrially important chlorinated hy-
drocarbon 1,2,3-trichloropropane (TCP). Mutants of DhaA
with increased thermostability, and improved activity on
TCP, have been obtained using directed evolution methods
(23, 24). DhlA uses preferably short chain haloalkanes (C2-
C4) and exhibits the highest catalytic efficiency on 1,2-
dibromoethane and 1,2-dichloroethane, whereas DhaA was
not active on the latter compound (20, 25, 26). For DhlA,
the rates of the separate steps involved in the dehalogenation
pathway of its “natural substrate” 1,2-dichloroethane and the
brominated analogue 1,2-dibromoethane have been estab-
lished by applying a transient kinetic approach using a
combination of rapid-quench-flow and stopped-flow fluo-
rescence methodology. These studies showed that maximum
turnover is controlled by a slow conformational change prior
to halide release (20, 27). For DhaA, such an analysis has
not been carried out. However, to understand the selectivity
of this dehalogenase on a mechanistic level, evaluation of
the kinetic mechanism of DhaA is imperative. This paper
describes such a kinetic characterization of DhaA. The
steady-state kinetics were investigated with a range of mono-,
di-, and trihalogenated propanes, which served as a basis
for pre-steady-state analysis of 1,3-dibromopropane conver-
sion. Since fluorescence quenching of DhaA is unsuitable
for monitoring substrate and product binding, the kinetics
of 1,3-dibromopropane conversion were studied using rapid-
quench-flow techniques. The results of this work allow a
comparison of the kinetic mechanism of DhaA and DhlA,
and in this report, we highlight similarities and differences
between these two haloalkane dehalogenases.
MATERIALS AND METHODS
Materials. All halogenated compounds that were used were
obtained from commercial suppliers (Across, Merck, and
Aldrich). 2H2O (99.8%, v/v) was purchased from Isotec Inc.
(Miamisburg, OH).
Protein Expression and Purification. The haloalkane
dehalogenase gene dhaA was amplified by PCR using total
DNA of Rhodococcus sp. strain m15-3 as a template. The
isolated dhaA gene was cloned into the T7-based expression
vector pGEF+, and overexpressed in Escherichia coli BL21-
(DE3) (10). Because of the introduction of an NcoI restriction
site for translational fusion into the ATG start codon, the
second amino acid was changed from Ser to Ala.
The haloalkane dehalogenase was expressed and purified
by DEAE-cellulose and hydroxylapatite chromatography
according to the method of Schanstra et al. (28). Typically,
1.5 g of purified DhaA was isolated from a 5 L culture of
E. coli BL21(DE3). The enzyme solution was concentrated
with an Amicon ultrafiltration cell using a PM10 filter and
stored at -20 or 4 °C in TEMAG [10 mM Tris-SO4 (pH
7.5), 1 mM EDTA, 1 mM â-mercaptoethanol, 3 mM sodium
azide, and 10% (v/v) glycerol]. The concentration of the
purified DhaA was measured spectrophotometrically at 280
nm. An absorbance of 1 corresponds to 0.54 mg/mL, as
calculated with DNAstar (DNASTAR, Inc., Madison, WI).
The purity of the dehalogenase was analyzed by SDS-
PAGE.
Steady-State Kinetics. Dehalogenase assays were carried
out at 30 °C in 50 mM NaHCO3/NaOH buffer (pH 9.4) using
colorimetric detection of halide release from halogenated
substrates (3). Solvent kinetic isotope effects were determined
by performing dehalogenase assays in buffer containing
halogenated substrate, and increasing concentrations of 2H2O.
The Km and Vmax values were calculated from the initial rate
of (halo)alcohol production, determined by gas chromatog-
raphy, or from halide production rates, determined colori-
metrically (26). The KM value for 1,3-dibromopropane was
determined by following substrate depletion by gas chro-
matography. A tube with a sufficient amount of enzyme and
50 íM 1,3-dibromopropane was incubated at 30 °C, and at
different times within 20 min, samples of 1 mL were taken.
The samples were extracted with 1.5 mL of diethyl ether
containing 0.05 mM 1-bromohexane as the internal standard.
The organic phase was analyzed by gas chromatography.
Potassium bromide (80 mM), 3-bromo-1-propanol (20 mM),
and 2-bromoethanol (20 mM) were tested as product inhibi-
tors of 1,3-dibromopropane conversion by DhaA. Conversion
of 1,3-dibromopropane was followed by gas chromatography.
Rapid-Quench-Flow Measurements. Single-turnover and
pre-steady-state burst experiments on 1,3-dibromopropane
conversion were carried out in 50 mM NaHCO3/NaOH (pH
9.4) and 1 mM dithiothreitol at 30 °C using a Kintek RQF-3
rapid-quench-flow apparatus (KinTek Corp., State College,
PA). The concentrations of enzyme and substrate cited in
the text are those after mixing and during the enzymatic
reaction. The reaction was initiated by rapidly mixing equal
volumes (50 íL) of a concentrated enzyme solution and a
freshly prepared 1,3-dibromopropane solution. At appropriate
times, ranging from 2 ms to 0.5 s, the reaction was quenched
with 120 íL of 0.8 M H2SO4. The quenched reaction mixture
was directly extracted with 1.5 mL of ice-cold diethyl ether
containing 0.05 mM 1-bromohexane as the internal standard,
and then neutralized by the addition of NaHCO3. The ether
phase containing noncovalently bound substrate and halo
alcohol was analyzed by gas chromatography, and the
amount of bromide in the water phase was measured by ion
chromatography.
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Data Analysis. Numerical integration was performed by
using Dynafit (29) (Biokin, Ltd., Madison, WI). The entire
data set was fit to a single mechanism and a single set of
rate constants. The 95% confidence interval for the rate
constants was determined by a systematic search in the
parameter space using an algorithm implemented in the
program. An iterative process, varying one rate constant at
a time, was used to fit the data. Initial estimates of k2, k3,
and k4 were obtained from the fits of the pre-steady-state
burst data to the biphasic burst equation (30):
where A is the amplitude of the burst, kb is the first-order
rate constant of the pre-steady-state exponential phase, and
kss is the rate of the linear phase which corresponds to the
steady-state rate. The data were fit to the biphasic burst
equation by nonlinear regression analysis using SigmaPlot
(Jandell Scientific).
Analytical Methods. Concentrations of organic halogenated
compounds were quantitatively determined by gas chroma-
tography on a Chrompack 438S gas chromatograph equipped
with a flame ionization detector and an HP wax column
(length of 25 m, inner diameter of 0.2 mm, and film thickness
of 0.2 ím) (Hewlett-Packard). Nitrogen was used as the
carrier gas (50 kPa), and the temperature program was as
follows: isothermal for 3 min at 45 °C followed by an
increase to 220 °C at a rate of 10 °C/min.
Bromide concentrations in the water phase were quanti-
tated by ion chromatography on a Dionex ion chromatograph
with an AS12A column (length of 25 cm and diameter of 4
mm) and an AG12A precolumn (length of 4 cm and diameter
of 4 mm). The carrier liquid was 270 mM Na2CO3 and 30
mM NaHCO3.
RESULTS AND DISCUSSION
Steady-State Kinetics of Halopropane ConVersion. The
dhaA gene was heterologously expressed under control of
the T7 promoter in E. coli BL21(DE3), and the dehalogenase
was purified to homogeneity. The purified enzyme was used
to determine the steady-state kinetic constants on a range of
halopropanes, including the important environmental chemi-
cals 1,2-dichloropropane and 1,2,3-trichloropropane. Both
chloro- and bromopropanes are substrates for DhaA (Table
1). In agreement with previous results, bromopropanes are
better substrates with turnover numbers (kcat) that are higher
than those of chlorinated analogues (25, 26). In terms of
catalytic efficiency (kcat/KM), 1,3-dibromopropane was the
best substrate. Furthermore, DhaA converted different bro-
minated propanes with a similar kcat value. The higher affinity
of DhaA for brominated compounds might be a consequence
of tight substrate binding in combination with a high rate of
carbon-bromine bond cleavage, as was observed for 1,2-
dibromoethane conversion by DhlA, the corresponding
enzyme from X. autotrophicus GJ10 (20). DhaA dehaloge-
nated mono- and dibrominated propanes with a catalytic
efficiency similar to that of DhlA, whereas the catalytic
efficiency of DhaA on 1,2,3-tribromopropane was 30-fold
higher (25, 26). This observation is consistent with the larger
active site cavity of DhaA that can probably better accom-
modate large bulky substrates such as 1,2,3-tribromopropane
(13). DhaA dehalogenated the different chlorinated propanes
with considerable differences in maximum turnover as well
as affinity. Within this series of substrates, DhaA has the
highest efficiency toward 1,3-dichloropropane. Both 1,2-
dichloropropane and 1,2,3-trichloropropane are poor sub-
strates. DhaA slowly dehalogenated 1,2,3-trichloropropane
with a low kcat and high KM, whereas no significant activity
was detected for 1,2-dichloropropane. The opposite applies
for DhlA, which is not active on 1,2,3-trichloropropane but
slowly dehalogenated 1,2-dichloropropane (20, 26).
Compared to DhaA, the Xanthobacter dehalogenase has
a more restricted substrate range. The latter dehalogenase
exhibits the highest activity on smaller compounds such as
its natural substrate 1,2-dichloroethane and the brominated
analogue and nematocide 1,2-dibromoethane (20). Interest-
ingly, DhaA converted 1,2-dibromoethane at a steady-state
rate that is 4-5-fold higher than that found with DhlA, even
though 1,2-dichloroethane is not a substrate for DhaA (20,
25, 26).
DhaA was also active on polar compounds such as
3-bromo-1-propanol and 2-bromoethanol, which are the
products of enzymatic dehalogenation of 1,3-dibromopropane
and 1,2-dibromoethane, respectively. Maximum turnover
rates for these halo alcohols were similar to those found for
the brominated propanes, whereas the KM values were higher.
Both halohydrins were examined as product inhibitors of 1,3-
dibromopropane conversion. DhaA was inhibited by 3-bromo-
1-propanol, whereas 2-bromoethanol did not inhibit 1,3-
dibromopropane conversion. Since 3-bromo-1-propanol is a
substrate for DhaA with a reasonably high affinity, this
substrate is most likely a competitive inhibitor.
Bromide also inhibited DhaA. In the presence of 80 mM
bromide, the maximum turnover rate on 1,3-dibromopropane
dropped 10-fold. Since the KM is too low to measure
accurately, we were not able to determine a clear effect on
the KM in the presence of bromide. However, it seems likely
that halide binds to both the free enzyme and the enzyme-
substrate complex, since X-ray crystallography data for
different haloalkane dehalogenases indicate that halides can
bind in the active site region of these enzymes (12, 13, 16,
31). This suggests that bromide exerts a noncompetitive type
of inhibition, most likely mixed, on DhaA. Surprisingly,
Schindler et al. (25), using an assay dependent on pH
changes, did not find halide inhibition of DhaA at concentra-
tions up to 80 mM.
Table 1: Steady-State Activity Parameters of Purified DhaA at pH
9.4 and 30 °C
substrate kcat (s-1) Km (mM) kcat/Km (M-1 s-1)
1-chloropropane 0.48 1.0 480
1,2-dichloropropane a
1,3-dichloropropane 1.3 0.63 2000
1,2,3-trichloropropane 0.08 2.2 36
1-bromopropane 2.7 0.6 4500
1,2-dibromopropane 2.3 1.0 2300
1,3-dibromopropane 2.7 0.005 540000
1,2,3-tribromopropane 3.6 0.3 12000
1,2-dibromoethane 14.3 4.0 3600
3-bromo-1-propanol 3.0 3.3 910
2-bromoethanolb >3.0 >11.0 >272
a Not detectable, detection limit of <10 milliunits/mg of protein at
10 mM substrate. b Due to the high background, only kcat/KM could be
determined, setting lower limits for the kcat and KM values. The kcat
values had errors of less than 15%, and the Km values had errors of
less than 25%.
product ) A  exp(-kbt) + ksst
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Comparing the maximum turnover rates of DhaA with
halopropanes using H2O or 2H2O as a solvent provides
information about the position of the slowest step in the
catalytic cycle. A 2H2O solvent kinetic isotope effect on the
maximum turnover rate is often indicative of the cleavage
of H-X (X is N or O) bonds in the rate-determining step,
but can also be due to a conformational change (32).
Cleavage of an X-D bond is several times slower than that
of an X-H bond. In the dehalogenase reaction, cleavage of
an H-X bond occurs during hydrolysis of the alkyl-enzyme
intermediate, a process that is facilitated by proton abstraction
from water by the base catalyst histidine. However, experi-
ments with DhlA showed that the catalytic rate was also
decreased in 2H2O due to a decrease in the overall flexibility
of a part of the protein that has to undergo a conformation
change for allowing product release (27). Therefore, the use
of deuterium oxide as a solvent is expected to reduce the
maximum turnover rate if the slowest step is hydrolysis of
the alkyl-enzyme intermediate or a slow step that requires
conformational changes, but not if cleavage of the carbon-
halogen bond is the slowest step.
The occurrence of a solvent kinetic isotope effect was
tested for different halopropanes. In the presence of 95%
deuterium oxide, VH/Vobs ratios of 2.5 and 2 were found for
1,3-dibromopropane and 1,2,3-tribromopropane, respectively
(Figure 1). With 1,2,3-trichloropropane, however, no such
decrease in the kcat was observed. Thus, during 1,2,3-
trichloropropane conversion, there appears to be a different
rate-determining step, i.e., carbon-chlorine bond cleavage
(Figure 1). The kinetic mechanism of DhaA was further
investigated by a transient kinetic approach using 1,3-
dibromopropane as a model substrate because of the high
affinity of the dehalogenase for this compound.
Transient-State Kinetic Analysis of 1,3-Dibromopropane
ConVersion. The chemical reaction steps involved in deha-
logenation of 1,3-dibromopropane by DhaA were examined
using rapid-quench-flow kinetic methods. To identify the
rate-limiting step in the overall reaction pathway, we
conducted a pre-steady-state burst experiment and followed
product formation. The reaction was initiated by mixing an
excess of 1,3-dibromopropane (final concentration of 2.5
mM) with DhaA (final concentration of 540 íM). After
various times, the reactions were quenched and the amounts
of bromide and 3-bromo-1-propanol were quantitated. A pre-
steady-state burst was found both for bromide and 3-bromo-
1-propanol, with observed exponential burst rate constants
of 250 and 10 s-1, respectively (Figure 2A). This fast initial
rate was followed by a slower steady-state rate of product
formation of 2.8 s-1 (kss divided by the active enzyme
concentration), which is in good agreement with the kcat of
2.7 s-1 determined from halide production rates that were
found after manual mixing. The active enzyme concentration
was obtained from the amplitude of the bromide burst and
corresponded apparently to 65% of the enzyme concentration
as was determined spectrophotometrically.
The observation of a pre-steady-state burst for both
products indicated that a step after chemical catalysis,
presumably product release, is rate-limiting. Furthermore, it
implies that there are at least three steps following substrate
binding (Scheme 1): formation of the alkyl-enzyme inter-
mediate (step 2), hydrolysis of the alkyl-enzyme intermedi-
FIGURE 1: Solvent kinetic isotope effect on haloalkane dehalogenase
activity. The activity (Vobs) was determined at increasing concentra-
tions of 2H2O. The ratio between the dehalogenase activity in 1H2O
(VH) and in 2H2O (Vobs) was plotted vs various 1H2O/2H2O ratios:
(9) 5 mM 1,3-dibromopropane, (2) 2 mM 1,2,3-tribromopropane,
(b) 10 mM 1,2,3-trichloropropane, and (0) 10 mM 1,2-dibromo-
ethane as substrates.
FIGURE 2: Dehalogenation of 1,3-dibromopropane under pre-steady-
state conditions. (A) Pre-steady-state burst of bromide production
(0) and 3-bromo-1-propanol production (2). Reactions were
conducted by mixing DhaA (520 íM) with excess 1,3-dibromopro-
pane (2500 íM) in 50 mM NaHCO3/NaOH (pH 9.4) and 1 mM
dithiothreitol (pH 9.4). (B) Kinetics of a single turnover in 50 mM
NaHCO3/NaOH (pH 9.4). A solution of DhaA (750 íM) and 1,3-
dibromopropane (400 íM) was mixed to initiate the reaction. The
disappearance and formation of 1,3-dibromopropane (b), bromide
(0), and 3-bromo-1-propanol (2) were monitored. The curves are
numerical fits generated with Dynafit using the rate constants
summarized in Table 2.
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ate (step 3), and product release (step 4). Because the amount
of bromide present during steady-state turnover was ap-
proximately the same as the amount of 3-bromo-1-propanol
produced, there was no significant accumulation of a covalent
enzyme-substrate intermediate, which is in agreement with
a slow step occurring after hydrolysis of the intermediate.
The exponential burst phases of bromide and 3-bromo-1-
propanol production largely define rate constants k2 and k3,
respectively. The steady-state rate kss defines the rate constant
of product release k4, which corresponds to a simplified step
representing an unknown unimolecular rate-limiting event.
The kinetics of a single turnover of 1,3-dibromopropane
conversion by DhaA are shown in Figure 2B. Excess DhaA
(750 íM) was rapidly mixed with 1,3-dibromopropane (400
íM), and substrate depletion and product formation were
monitored. Within the first 15 ms of the reaction, substrate
disappeared and simultaneously bromide production reached
its maximum, whereas hardly any 3-bromo-1-propanol was
observed. Substrate depletion and 3-bromo-1-propanol pro-
duction curves crossed at 70 íM, indicating that hydrolysis
of the covalent intermediate occurred at a much lower rate
than its formation. This resulted in a very rapid accumulation
of the alkyl-enzyme intermediate. The initial dehalogenation
step appears to be irreversible, since all halide was com-
pletely released during the initial phase of alcohol production.
Proposed Kinetic Mechanism for Haloalkane Dehaloge-
nase DhaA. A minimal model consisting of four steps
consistent with the pre-steady-state data (Figure 3 and
Scheme 1) was constructed.
The mechanism involves substrate binding, formation of
an alkyl-enzyme intermediate and simultaneous cleavage
of the carbon-bromine bond, hydrolysis of the alkyl-
enzyme intermediate, and finally release of the products from
the enzyme active site. On the basis of the observation of a
product burst, the first three steps occur at a rate that is faster
than the rate of steady-state turnover, whereas step 4, product
release, is proposed to limit maximum turnover. The overall
dehalogenase reaction was considered irreversible since no
products are observed in the reverse reaction. To determine
the rate constants for the individual steps, both pre-steady-
state burst and single-turnover data were combined and fitted
to the mechanism presented in Scheme 1 by numerical
integration using Dynafit. The adjustable parameters were
all five rate constants that appear in the reaction mechanism,
and the resulting best fit values are summarized in Table 2.
Initially, the amplitude of the bromide burst was lower than
expected. A decreased burst amplitude may be governed by
several factors, such as characteristics of the reaction kinetics,
an internal equilibrium, or that a fraction of the enzyme is
not participating in the reaction (30). In a recent paper,
Lewandowicz et al. suggested, on the basis of the measure-
ment of a chlorine kinetic isotope effect, that the dehaloge-
nation step during conversion of 1,2-dichloroethane by DhlA
is reversible and that the overall irreversibility is caused by
the hydrolysis of the covalent intermediate (33). Therefore,
we also performed burst simulations using a model that
includes a reversible dehalogenation step. However, these
simulations could not explain the data of both pre-steady-
state burst and single-turnover experiments. Furthermore, the
observation that during a single turnover essentially all
substrate is transiently present as a covalent intermediate
excludes reversibility of the first chemical step (see above).
The mechanism presented in Scheme 1 could describe the
experimental data if the active enzyme concentration present
during the burst experiment was 65% of the total amount
of protein, indicating that a significant fraction of DhaA was
not participating in the reaction under these conditions.
Therefore, the concentration of DhaA was optimized for each
data set. The best fit values of the optimized enzyme
concentrations were 343 and 660 íM for the pre-steady-
state burst and single-turnover experiment, respectively. The
fits in panels A and B of Figure 2 were computed using
the kinetic model of Scheme 1 and the rate constants in
Table 2.
The results clearly show that substrate binding and
chemical catalysis are not the steps that limit maximum
turnover. Using single-turnover conditions, the rate of
substrate binding appeared to be faster than the rate of
chemical catalysis. At a 1,3-dibromopropane concentration
of 400 íM, the pseudo-first-order rate constant (k1[S]) was
400 s-1. The data did not allow extraction of a unique value
for the rate of substrate dissociation k-1, but a solution could
be obtained using computer simulations to the mechanism
in Scheme 1 together with the rate constants in Table 2.
These simulations were constrained by the experimental KM
and kcat/KM. The rate constants k2-k4 were determined by
fitting the kinetic scheme to the rapid-quench data. Carbon-
bromine bond cleavage and the simultaneous formation of
the alkyl-enzyme intermediate (k2) occurred with a rate of
FIGURE 3: Reaction mechanism of haloalkane dehalogenase. After
formation of the Michaelis complex, the dehalogenation reaction
proceeds via a nucleophilic attack of an aspartate side chain on the
halo-substituted carbon atom of the substrate, thereby displacing
the halogen ion and forming an alkyl-enzyme intermediate. This
covalent intermediate is subsequently hydrolyzed by a water
molecule activated by the base catalyst histidine, yielding the (halo)-
alcohol.
Scheme 1
Table 2: Pre-Steady-State Kinetic Constants of DhaA for




substrate binding k1 1.0 íM-1 s-1 (0.8-2.5)
substrate dissociationa k-1 60-300 s-1
carbon-bromine bond cleavage k2 300 s-1 (249-372)
hydrolysis of the alkyl-enzyme
intermediate
k3 14.8 s-1 (13.5-16.3)
product release k4 3.9 s-1 (3.4-4.6)
a Determined from steady-state parameters and computer simulation.
Numbers in parentheses represent the 95% confidence intervals.
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300 s-1. The rate of hydrolysis of the intermediate (k3),
obtained from the 3-bromo-1-propanol traces, was 20-fold
lower but still higher than kcat. The linear phase after the
pre-steady-state burst defined the rate of product release (k4)
at 3.9 s-1, and was close to the experimental kcat. This step
is simplified with a first-order rate constant, which could be
a conformational change or another manner of slow release
of products from the enzyme active site. Calculation of the
steady-state kinetic parameters for a four-step kinetic model
(Scheme 1), in which kcat ) (k2k3k4)/(k2k3 + k2k4 + k3k4),
KM ) [k3k4(k-1 + k2)]/[k1(k2k3 + k2k4 + k3k4)], and kcat/KM
) (k1k2)/(k-1 + k2), using the obtained individual constants,
yielded values which are in close agreement with the
experimentally determined values, for both kcat (3.0 s-1) and
KM (3.7 íM).
A comparison of the mechanism of DhaA with that of
DhlA showed a similar overall mechanism consisting of four
main steps with a rate-limiting release of products from the
active site. For DhlA, it was established using stopped-flow
fluorescence quenching that the rate of release of the halide
ion from the active site was limited by a conformational
change in the cap domain that is necessary to allow water
to enter the active site and solvate the halide ion (27). This
conformational change separates the halide release step from
the substrate binding step, which explains that halide is not
a competitive inhibitor. Bromide also was not a competitive
inhibitor in DhaA. Although release of the halide ion in
DhaA cannot be assessed directly by stopped-flow fluores-
cence experiments, we have several reasons to propose that
bromide release is probably not the rate-limiting step. In the
first place, if for different brominated compounds bromide
release would be rate-determining and the reaction sequence
is the same, then they should all be hydrolyzed with the same
value of kcat (20). However, the high rate of hydrolysis of
1,2-dibromoethane by DhaA shows that bromide can be
released at a rate of at least 14.3 s-1, which is 4-5-fold faster
than the maximum turnover rate with 1,3-dibromopropane.
The rate-determining step for 1,2-dibromoethane conversion
is also at the end of the reaction sequence as indicated by
the occurrence of a 2H2O solvent kinetic isotope effect. In
addition, product inhibition studies suggest that bromide
exerts a noncompetitive type of inhibition on DhaA, and thus,
bromide apparently does not interfere with substrate binding.
Therefore, it is most likely that bromide is immediately
released from the product-binding pocket after cleavage of
the carbon-bromine bond. Hence, it seems plausible that
the release of the product alcohol from the active site is rate-
determining. The difference in kcat between 1,2-dibromo-
ethane and 1,3-dibromopropane might then be due to a faster
diffusion of 2-bromoethanol out of the active site than of
3-bromo-1-propanol. DhaA also has a higher affinity for the
latter halohydrin. Nevertheless, a different rate-determining
step for 1,2-dibromoethane could not be excluded.
Another reason to assume that bromide is not the last
product released from the active site comes from examination
of the crystal structures of DhaA and DhlA. With both
dehalogenases, the active site cavity is lined with mainly
hydrophobic residues providing an optimal microenviron-
ment, with respect to charge and polarity and by stabilizing
reaction intermediates, for the efficient conversion of sub-
strate to product. Export of the halide ion from the active
site cavity into the solvent requires ion destabilization and
solvation of the halide ion by water. Compared to DhlA,
the active site of DhaA is connected to the solvent by a much
larger tunnel and is less buried in the protein core (12). In
addition, Newman et al. suggested that at pH 7-9, where
the enzyme activity is measured, the cap domain of DhaA
becomes more flexible (13). These observations suggest that
the accessibility of water to the active site may be facilitated,
allowing a faster exchange of the halide ions and water with
the bulk solvent. Furthermore, while DhaA and DhlA are
considerably homologous in sequence and structure in the
central catalytic domain, there are some differences in the
active site residues involved in catalysis which might
influence different kinetic steps (21). In DhlA, Trp125 forms
a halide-binding site in the active site together with Trp175.
The function of the latter tryptophan residue is probably
fulfilled by a Phe and Asn residue in DhaA, which is
proposed to result in weaker binding of the halide ion that
is cleaved off (12, 21). Another structural feature that may
facilitate halide release in DhaA is the different topological
position of the carboxylate functionality of the triad. The
triad acid group in DhaA follows â-strand 6 rather than
â-strand 7 as in DhlA and most other R/â-hydrolase fold
enzymes (13, 22). Mutagenesis of active site residues Trp175
and Asp260 of DhlA, and subsequent structural and kinetic
analysis, corroborated the above observations. These experi-
ments showed that halide release in these mutants was
accelerated and not limiting maximum turnover as was found
for wild-type DhlA (34, 35).
Summarizing, we defined the steps of a minimal dehalo-
genation mechanism that is sufficient to explain the steady-
state kinetic data. Pre-steady-state kinetic analysis of 1,3-
dibromopropane conversion by DhaA showed that substrate
binding and chemical catalysis occur faster than the steady-
state rate which corresponds to product release. The overall
mechanism by which DhaA catalyzes dehalogenation is
similar to that of DhlA, but the rate-determining step of DhaA
may be different. In DhaA, the less efficient stabilization of
the leaving halogen, the different topological arrangement
of the triad acid Glu130, and the much larger and less buried
active site cavity may allow faster diffusion of the halide
ion out of the active site. Together with the high activity on
1,2-dibromoethane, these observations support the idea that
bromide release is not rate-determining during conversion
of 1,3-dibromopropane. Release of the product alcohol from
the DhaA active site is therefore proposed to be the overall
rate-limiting step, which is largely determined by the size
and affinity of the product alcohol, explaining the difference
in kcat between 1,2-dibromoethane and 1,3-dibromopropane
conversion.
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